Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

20 May 2023 (13:34 - 14:42)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Rafael Rascon Sabido

Mexican Institute of Social Security (IMSS), Veracruz (Mexico)

6 More presentations in this session

Presentation thumbnail

Aspirin and long-Term risk of heart failure in patients with high atherosclerotic risk

Associate Professor W. Wongcharoen (Chiang Mai, TH)

Abstract Slides

Presentation thumbnail

Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure

Doctor M. Davies (The Woodlands, US)

Abstract Slides

Presentation thumbnail

Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction

Doctor B. Li (Basildon, GB)

Abstract Slides

Presentation thumbnail

Reverse cardiac remodeling effects of sacubitril/valsartan in adults with congenital heart disease

Doctor A. Ferreira (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Prevalence of sodium glucose co-transporter 2 inhibitor related erythrocytosis (polycythaemia) in real world heart failure patients: a warning for the daily clinical practice

Mr E. Bruwiere ('s-Hertogenbosch, NL)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 2

The Event

Event poster

Heart Failure 2023

20 May 2023 13:34 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources